Recalls / Active ingredient / Budesonide

Budesonide

7 FDA drug recalls involving the active ingredient “Budesonide”.

Date	Class	Product	Firm
2025-06-30	Class II	Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manuf	Cipla USA, Inc.
2025-05-14	Class II	Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhal	AsttraZeneca Pharmaceuticals LP
2024-01-08	Class II	Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL,	Teva Pharmaceuticals USA, Inc
2022-09-15	Class II	Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose	CIPLA
2021-03-15	Class II	Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 80/4.5 budesonide 80 mcg/formoterol fumarate d	Cardinal Health Inc.
2013-01-11	Class III	PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension (30 ampules/carton) NDC: 0186-1988-04	AstraZeneca LP
2013-01-11	Class III	PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04	AstraZeneca LP